ALPHA TAU MEDICAL LTD (DRTS) Stock Earnings & Estimates
USA - NASDAQ:DRTS - IL0011839383 - Common Stock
4.05 USD
-0.07 (-1.7%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A 340.43% | N/A 14.39% | N/A 114.00% | N/A 52.23% | |||||||
| EBITDA YoY % growth | -7.94M | -9.15M -15.24% | -13.01M -42.19% | -31.16M -139.51% | -34.606M -11.06% | -34.94M -0.97% | N/A -28.62% | N/A 69.45% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -8.01M | -9.24M -15.36% | -13.79M -49.24% | -32.14M -133.07% | -35.68M -11.01% | -36.042M -1.01% | N/A -12.04% | N/A 20.61% | N/A 186.11% | N/A -139.79% | N/A 462.58% | N/A 120.10% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -0.66 -148.87% | -0.42 36.36% | -0.45 -7.14% | N/A -10.77% | N/A 25.78% | N/A 193.61% | N/A -114.73% | N/A 1,060.00% | N/A 100.00% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.12 -17.56% | -0.13 1.33% | -0.13 -4.83% | -0.13 3.23% | -0.12 0.22% | -0.12 4.57% | -0.11 10.81% | -0.10 18.92% | -0.09 21.74% | -0.10 16.67% |
| Revenue Q2Q % growth | 108.803K | 357K | 163.2K | 290.7K | 2.519M 2,215.19% | 3.886M 988.52% | 4.406M 2,599.75% | 5.202M 1,689.47% | ||
| EBITDA Q2Q % growth | -10.754M -20.00% | -10.983M -19.75% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -10.253M -23.68% | -10.794M -5.06% | -10.683M -14.78% | -10.659M -10.48% | -10.307M -0.53% | -11.3M -4.68% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.13 -18.18% | -0.12 | -0.01 | -11.55% |
| Q1 2025 Q2Q % growth | -0.12 -9.09% | -0.13 | 0.01 | 7.55% |
| Q4 2024 Q2Q % growth | -0.13 -18.18% | -0.12 | -0.01 | -5.04% |
| Q3 2024 Q2Q % growth | -0.10 -42.86% | -0.12 | 0.02 | 18.47% |
| Q2 2024 Q2Q % growth | -0.11 8.33% | -0.13 | 0.02 | 13.73% |
| Q1 2024 Q2Q % growth | -0.11 8.33% | -0.13 | 0.02 | 14.58% |
| Q4 2023 Q2Q % growth | -0.11 -120.00% | -0.12 | 0.01 | 8.41% |
| Q3 2023 Q2Q % growth | -0.07 -75.00% | -0.12 | 0.05 | 42.81% |
| Q2 2023 Q2Q % growth | -0.12 -300.00% | -0.13 | 0.01 | 8.94% |
| Q1 2023 Q2Q % growth | -0.12 77.78% | -0.11 | -0.01 | -6.76% |
| Q4 2022 Q2Q % growth | -0.05 | -0.11 | 0.06 | 55.94% |
| Q3 2022 Q2Q % growth | -0.04 | -0.12 | 0.08 | 66.10% |
| Q2 2022 Q2Q % growth | -0.03 | -0.12 | 0.09 | 75.28% |
| Q1 2022 Q2Q % growth | -0.54 | -0.07 | -0.47 | -620.29% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 33.997K | -33.997K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 1.5% | -1.99% | 0% | -3.86% |
| Revenue | N/A | N/A | N/A | N/A |